Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL – long-term follow-up from the prospective ALL-SCT 2003 trialAnna Eichinger, Michael H. Albert, Alexander Claviez et al.|Leukemia|2022Cited by 26
Presence of centromeric but absence of telomeric group B KIR haplotypes in stem cell donors improve leukaemia control after HSCT for childhood ALLFlorian Babor, Roland Meisel, Christina Peters et al.|Bone Marrow Transplantation|2019Cited by 21
Haematopoietic stem cell transplantation after reduced intensity conditioning in children and adolescents with chronic myeloid leukaemia: A prospective multicentre trial of the <scp>I‐BFM</scp> Study GroupHerbert Pichler, Adriana Balduzzi, Petr Sedláček et al.|British Journal of Haematology|2024Cited by 6
Impact of minimal residual disease on the outcome of hematopoietic stem cell transplantation for childhood acute lymphoblastic leukemia within the FORUM TrialAdriana Balduzzi, Marianne Ifversen, Evgenia Glogova et al.|Haematologica|2025Cited by 5